Recital 10, Decision No 1/2026 of the Joint Veterinary Committee set up by the Agreement between the…

In forcesince 24 Jul 2026

The prudent use of antimicrobials is a cornerstone in addressing antimicrobial resistance (AMR). Switzerland and the European Union are actively combatting AMR through action plans based on the ‘One Health’ approach. Switzerland will apply the same provisions as those set out in Article 107 (with the exception of paragraph 6), in conjunction with Article 37(5) of Regulation (EU) 2019/6 [Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (OJ L 4, 7.1.2019, p. 43, ELI: http://data.europa.eu/eli/reg/2019/6/oj).] of the European Parliament and of the Council, as regards the rules on the use of antimicrobial medicinal products in productive animals, the prohibition of use in productive animals of designated antimicrobials or of groups of antimicrobials reserved for the treatment of certain infections in humans, and for controls of imports of animals and products of animal origin originating in third countries. Trade in animals and products of animal origin between Switzerland and the European Union may therefore be conducted without an accompanying official certificate to demonstrate compliance with the restrictions applicable to the use of antimicrobial medicinal products. These provisions should be added in Appendices 2, 3, 5, 6 and 10 to Annex 11 to the Agriculture Agreement.